ADVERTISEMENT

Elizabeth Edwards’ Death Drives Advocates at SABCS

News of Elizabeth Edwards' death heightens a sense of urgency at the 33rd annual San Antonio Breast Cancer Symposium among patients, survivors and advocates.

BY KATHY LATOUR
PUBLISHED WEDNESDAY, DECEMBER 8, 2010
Talk about this article with other patients, caregivers, and advocates in the Breast CURE discussion group.
There is a sense of urgency among the 36 patient advocates gathered in a hotel meeting room before the beginning of the San Antonio Breast Cancer Symposium. Having just arrived, most are hearing for the first time about the death of Elizabeth Edwards from metastatic breast cancer.

Little is said about Edwards as the women introduce themselves, each beginning with her number of years of survivorship and some adding details, such as HER2 status and whether she is triple negative or metastatic. Then they tell of their affiliations back home where they work on research, education or policy at the community, state or national level:  SHARE, Susan G. Komen for the Cure, the National Breast Cancer Coalition, Y-ME, Young Survival Coalition, Gilda’s Club and others, as well as national organizations in Nigeria, New Zealand, Japan, Australia, Egypt and Scotland.

They have come to learn all they can to return home and effect change. Edwards’ death is an unneeded exclamation point about the importance of their mission.

The women have come on scholarship from the Alamo Breast Cancer Foundation, which for 12 years has brought patient advocates to SABCS. The program began when Charles Coltman Jr., MD, a co-founder of the symposium, approached breast cancer survivors Joy Moose and Dale Eastman about creating an advocacy program for the symposium. Coltman was well acquainted with the two women, who had begun attending the physician-only symposium to educate themselves on breast cancer research. When more advocates began appearing, he asked them to formalize an advocacy program for survivors.

“We said, ‘Yes,’ ” says Moose. “Then we got out in the hall, hugged, and said, ‘So how do we do this?’ ”

There were nine survivors in the first “class.” Today, the advocates come from 13 states and six foreign countries, their attendance covered by grants totaling more than $313,500. To date, 367 advocates have completed the program.

For the next four days, these women, all breast cancer survivors, will be listening to presentations on the latest research, with each assigned one session to write up for the educational CD that will be created for distribution across the country in early 2011. “We only take women who have already been through Project Lead,” Eastman says, referring to the intense basic science program offered by the National Breast Cancer Coalition that prepares advocates to sit on advisory and evaluative panels and boards, such as the Department of Defense Peer Reviewed Board. The advocates agree to attend a Project Lead advanced topics session, write a “hot topic” and work with mentors to help clarify their topic.

Every day has additional discussion and education sessions, meaning the woman are busy from morning to night. And even then, they often huddle in groups to share information on the latest advocacy accomplishments. No one has to remind them of the importance of their work here.

Talk about this article with other patients, caregivers, and advocates in the Breast CURE discussion group.
ADVERTISEMENT
Related Articles
Telephone Intervention Helps Breast Cancer Survivors Set—and Meet—Lifestyle Goals
BY CHRISTINA IZZO
A new telephone-based intervention for breast cancer survivors is showing promise, and it involves them becoming more actively engaged in goal setting and problem solving with an eye toward accelerating their recovery by engaging in health-promoting activities such as exercise, stress management and healthy eating.
Diabetes May Predispose Women to More Advanced Breast Cancer
BY CHRISTINA IZZO
Breast cancer patients with diabetes were significantly more likely to be diagnosed with advanced-stage breast cancer than those without diabetes.
Crossing Tumor Types: BRCA Experience Points Way to New Diagnostic Paradigm
BY MAURIE MARKMAN, MD
It is now well recognized that the presence of a molecular abnormality shown to be actionable in one tumor type may be highly clinically relevant in other malignancies.
Is Immunotherapy Ready for Prime Time in Breast Cancer?
BY ANDREW D. SMITH
Elizabeth A. Mittendorf, associate professor of surgical oncology at The University of Texas MD Anderson Cancer Center, discusses the progress and potential of immunotherapy in breast cancer treatment.
Angelina Jolie, Knowledge Is Not Enough
Two years ago, Angelina Jolie Pitt told the world that she held the BRCA1 mutation.
Related Videos
Health Advocate Amy Byer Shainman Discusses Risk Management of Hereditary Cancers
When it comes to managing your risk of cancer, especially when dealing with a familial cancer risk, "what is right for one person, may not be right for another," says Amy Byer Shainman.
Research Updates on HER2-Positive Breast Cancer from the 2015 Miami Breast Cancer Conference
Debu Tripathy, editor-in-chief of CURE magazine, discusses updates from the Miami Breast Cancer Conference, including the changing landscape of HER2-positive breast cancer.
Medical Updates from the 32nd Annual Miami Breast Cancer Conference
The evolution of the treatment for hormone receptor-positive breast cancer was a hot topic for this year's Miami Breast Cancer Conference. Debu Tripathy, CURE's editor-in-chief and breast oncologist, reports from the meeting.
Joan Lunden Discusses the Physical and Emotional Effects of Breast Cancer Treatment
Journalist Joan Lunden shares her experience with breast cancer, side effects and working through treatment.
Journalist Joan Lunden Discusses Her Breast Cancer Diagnosis and Treatment
Roy Firestone interviews longtime journalist, author and television host Joan Lunden on her recent breast cancer diagnosis and treatment.
Recent Publications
  • photo
    photo
    photo
    photo
    photo
  • photo
    photo
    photo
    photo
    photo
ADVERTISEMENT
$auto_registration$